Liu Chen Selected Research

Moxibustion

10/2019	Herbs-partitioned moxibustion improves intestinal epithelial tight junctions by upregulating A20 expression in a mouse model of Crohn's disease.
5/2019	Herbs-partitioned moxibustion alleviates aberrant intestinal epithelial cell apoptosis by upregulating A20 expression in a mouse model of Crohn's disease.
1/2019	[Herbal cake-partitioned moxibustion improves intestinal epithelial barrier dysfunction by suppressing TNF-α-mediated apoptosis pathway of intestinal epithelium in rats with Crohn's disease].
1/2019	Herbs-Partitioned Moxibustion Combined with Acupuncture Inhibits TGF-β1-Smad-Snail-Induced Intestinal Epithelial Mesenchymal Transition in Crohn's Disease Model Rats.
4/2017	Comparison of the analgesic effects between electro-acupuncture and moxibustion with visceral hypersensitivity rats in irritable bowel syndrome.
8/2016	[Effect of Electroacupuncture and Moxibustion on Visceral Pain and Expression of VR 1 and HSP 70 of "Tianshu" (ST 25) Region in Colorectal Distension-induced Visceral Hypersensitivity Rats].
1/2016	Comparison of Electroacupuncture and Moxibustion for Relieving Visceral Hypersensitivity in Rats with Constipation-Predominant Irritable Bowel Syndrome.
1/2016	Herb-partitioned moxibustion upregulated the expression of colonic epithelial tight junction-related proteins in Crohn's disease model rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liu Chen Research Topics

Disease

10	Infections 08/2022 - 07/2009
8	Neoplasms (Cancer) 01/2020 - 07/2004
5	Crohn Disease (Crohn's Disease) 10/2019 - 01/2016
4	Enteritis 01/2021 - 11/2013
3	Granuloma 02/2022 - 06/2019
3	Hernia (Hernias) 02/2022 - 06/2019
3	Carcinogenesis 01/2020 - 01/2013
3	Hypersensitivity (Allergy) 04/2017 - 01/2016
2	Head and Neck Neoplasms (Head and Neck Cancer) 11/2022 - 01/2015
2	Hemorrhage 03/2022 - 04/2020
2	Pain (Aches) 01/2022 - 06/2019
2	Hyperalgesia 01/2022 - 01/2021
2	Neoplasm Metastasis (Metastasis) 09/2021 - 01/2020
2	Cryptorchidism (Undescended Testes) 01/2021 - 06/2019
2	Sepsis (Septicemia) 01/2021 - 01/2017
2	Liver Diseases (Liver Disease) 12/2020 - 12/2015
2	Esophageal Atresia 04/2020 - 03/2020
2	Diabetic Foot 08/2018 - 01/2018
2	Ulcer 08/2018 - 01/2018
2	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 04/2017 - 01/2016
2	Carcinoma (Carcinomatosis) 01/2015 - 03/2014
2	Stomach Neoplasms (Stomach Cancer) 01/2014 - 01/2013
2	Virus Diseases (Viral Diseases) 12/2009 - 04/2009
1	Osteoarthritis 08/2022
1	Inguinal Hernia (Direct Inguinal Hernia) 01/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2022
1	Autistic Disorder (Autism) 01/2022
1	Tuberculosis (Tuberculoses) 01/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 09/2021
1	Hematoma 01/2021
1	Cardiomyopathies (Cardiomyopathy) 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Neuroinflammatory Diseases 01/2021
1	Neuralgia (Stump Neuralgia) 01/2021
1	Acute Coronary Syndrome 11/2020
1	Hypospadias 08/2020
1	Hypertrophic Pyloric Stenosis 05/2020
1	Wounds and Injuries (Trauma) 05/2020

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2004
4	VaccinesIBA 08/2022 - 04/2009
3	Peptides (Polypeptides)IBA 08/2022 - 04/2009
3	Apolipoproteins E (ApoE)IBA 01/2021 - 01/2016
3	Serine Proteases (Serine Protease)IBA 01/2020 - 01/2018
3	Glucose (Dextrose)FDA LinkGeneric 09/2019 - 01/2016
3	LipidsIBA 09/2019 - 12/2015
3	Eosine Yellowish-(YS) (Eosin)IBA 01/2017 - 01/2016
2	LipopolysaccharidesIBA 08/2022 - 01/2021
2	ApolipoproteinsIBA 01/2021 - 09/2019
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 01/2019
2	ChemokinesIBA 01/2020 - 07/2004
2	SodiumIBA 09/2019 - 01/2016
2	dapagliflozinIBA 09/2019 - 01/2016
2	Sodium-Glucose Transporter 2 InhibitorsIBA 09/2019 - 01/2016
2	Streptozocin (Streptozotocin)FDA Link 09/2019 - 01/2016
2	Biological ProductsIBA 01/2019 - 01/2013
2	Anti-Bacterial Agents (Antibiotics)IBA 08/2018 - 01/2018
2	Analgesics (Analgesic Drugs)IBA 04/2017 - 01/2016
2	Hematoxylin (Haematoxylon)IBA 01/2017 - 01/2016
2	Messenger RNA (mRNA)IBA 01/2015 - 05/2013
1	EpitopesIBA 08/2022
1	salicylhydroxamic acid (SHAM)IBA 01/2022
1	ZincIBA 01/2022
1	SaltsIBA 01/2022
1	Long Noncoding RNAIBA 09/2021
1	Taurine FDA Link 09/2021
1	AnnexinsIBA 09/2021
1	phospholambanIBA 01/2021
1	gamma-Aminobutyric Acid (GABA)IBA 01/2021
1	Dopamine (Intropin)FDA LinkGeneric 01/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2021
1	Aminobutyrates (Aminobutyric Acid)IBA 01/2021
1	Adenosine (Adenocard)FDA LinkGeneric 01/2021
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2021
1	Toll-Like Receptor 7IBA 01/2021
1	Sarcoplasmic Reticulum Calcium-Transporting ATPasesIBA 01/2021
1	CC ChemokinesIBA 12/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2020
1	Clopidogrel (Plavix)FDA Link 11/2020

Therapy/Procedure

8	Moxibustion 10/2019 - 01/2016
5	Therapeutics 12/2020 - 11/2009
4	Electroacupuncture 01/2021 - 01/2016
3	Sutures (Suture) 02/2022 - 06/2019
3	Artificial Respiration (Mechanical Ventilation) 04/2020 - 03/2020
2	Ligation 02/2022 - 11/2009
2	Traction 01/2022 - 06/2019
2	Operative Time 01/2022 - 01/2021
2	Thoracoscopes 04/2020 - 03/2020
2	Critical Care (Surgical Intensive Care) 04/2020 - 03/2020
2	Acupuncture Points (Acupuncture Point) 05/2019 - 04/2017
2	Drug Therapy (Chemotherapy) 03/2018 - 03/2014
2	Radiotherapy 09/2014 - 01/2014
1	Gastrostomy 11/2022
1	Analgesia 03/2022
1	Minimally Invasive Surgical Procedures 01/2021
1	Surgical Flaps 08/2020
1	Operative Surgical Procedures 08/2020
1	Pyloromyotomy 05/2020
1	Blood Transfusion (Blood Transfusions) 03/2020